RAJIV KANDALA: Open Payments
NPI 1376608059 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 13 payments from 5 companies in 2025. Trend: 2023 $847 · 2024 $324 · 2025 $418
Food & beverage: $373Education: $45
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $198 |
| AstraZeneca Pharmaceuticals LP | 1 | $101 |
| Neurocrine BioSciences, Inc. | 3 | $51 |
| Lilly USA, LLC | 1 | $45 |
| PFIZER INC. | 1 | $23 |
Products named: AUSTEDO XR, FARXIGA, INGREZZA, UZEDY.
Industry payments across IL — which companies pay providers there.
